Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2025-03-01
|
| Series: | Chinese Journal of Lung Cancer |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2025.103.01 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850187505035378688 |
|---|---|
| author | Editorial Office of Chinese Journal of Lung Cancer |
| author_facet | Editorial Office of Chinese Journal of Lung Cancer |
| author_sort | Editorial Office of Chinese Journal of Lung Cancer |
| collection | DOAJ |
| format | Article |
| id | doaj-art-166be23a5bbf46c3bbdb8d194e3abcbd |
| institution | OA Journals |
| issn | 1009-3419 1999-6187 |
| language | zho |
| publishDate | 2025-03-01 |
| publisher | Chinese Anti-Cancer Association; Chinese Antituberculosis Association |
| record_format | Article |
| series | Chinese Journal of Lung Cancer |
| spelling | doaj-art-166be23a5bbf46c3bbdb8d194e3abcbd2025-08-20T02:16:05ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872025-03-0128323623610.3779/j.issn.1009-3419.2025.103.01Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case ReportEditorial Office of Chinese Journal of Lung Cancerhttp://dx.doi.org/10.3779/j.issn.1009-3419.2025.103.01 |
| spellingShingle | Editorial Office of Chinese Journal of Lung Cancer Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report Chinese Journal of Lung Cancer |
| title | Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report |
| title_full | Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report |
| title_fullStr | Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report |
| title_full_unstemmed | Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report |
| title_short | Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report |
| title_sort | erratum crizotinib treatment for lorlatinib resistant met amplified eml4 alk fusion positive advanced lung adenocarcinoma a case report |
| url | http://dx.doi.org/10.3779/j.issn.1009-3419.2025.103.01 |
| work_keys_str_mv | AT editorialofficeofchinesejournaloflungcancer erratumcrizotinibtreatmentforlorlatinibresistantmetamplifiedeml4alkfusionpositiveadvancedlungadenocarcinomaacasereport |